BridgeMD
New treatment option for Acute Traumatic Spinal Cord Injury
Official title NEUROwave - Extracorporeal Shock Wave Therapy (ESWT) in Acute Traumatic Complete (AIS A) and Incomplete (AIS B-D) Cross-sectional Lesions on Motor and Sensory Function Within Six Months After Injury
ClinicalTrials.gov ID: NCT04474106
What this study is testing
- What it's testing
- It has been hypothesized that there are two mechanisms of acute traumatic spinal cord injury (SCI): the primary mechanical damage and the secondary injury due to additional pathological processes initiated by the primary injury. Neurological damage due to laceration, contusion, distraction or compression of the spinal cord is called ''primary injury''.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 99
You may be able to join if
- Patients with acute traumatic spinal injuries who are awake, responsive, and oriented at admission
- Patients from the age of 18 years
- Admission to hospital within 24 hours after injury
- Written consent to participate in the study
- Participation in the Austrian Spinal Cord Injury Study (ASCIS)-Registry (only for the Austrian hospitals)
You likely can't join if
- Patients who cannot cooperate or are not capable to give consent to participate
- Serious traumatic brain injuries that prevent accurate participation in study procedures and/or adequacy of informed consent Participation in other...
- Serious concomitant injuries that prevent the neurological initial assessment
- Preexisting neurological conditions that affect the primary endpoint of the study and potentially mask or reduce the therapeutic effect of the ESWT...
- High dose administration of corticosteroids
- Complete spinal cord transection
See the full eligibility criteria
- Patients with acute traumatic spinal injuries who are awake, responsive, and oriented at admission
- Patients from the age of 18 years
- Admission to hospital within 24 hours after injury
- Written consent to participate in the study
- Participation in the Austrian Spinal Cord Injury Study (ASCIS)-Registry (only for the Austrian hospitals)
- Patients who cannot cooperate or are not capable to give consent to participate
- Serious traumatic brain injuries that prevent accurate participation in study procedures and/or adequacy of informed consent Participation in other treatment clinical trials
- Serious concomitant injuries that prevent the neurological initial assessment
- Preexisting neurological conditions that affect the primary endpoint of the study and potentially mask or reduce the therapeutic effect of the ESWT application
- High dose administration of corticosteroids
- Complete spinal cord transection
- Patients with pacemakers or implantable defibrillators
- Patients who are using devices which are sensitive to electromagnetic radiation
- (potential) Pregnancy
- Patients with tumors
- Patients with severe coagulation disorders
The study team makes the final eligibility decision.
Where it's taking place
- Innsbruck, Tyrol, Austria
- Bad Häring, Austria
- Feldkirch, Austria
- Graz, Austria
- Klagenfurt, Austria
- Klosterneuburg, Austria
- Linz, Austria
- Salzburg, Austria
- Sankt Pölten, Austria
- Vienna, Austria
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 99 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Innsbruck, Tyrol, Austria; Bad Häring, Austria; Feldkirch, Austria; Graz, Austria; Klagenfurt, Austria; Klosterneuburg, Austria and 4 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.